REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmablock Sciences (Nanjing), Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmablock Sciences (Nanjing), Inc. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Pharmablock Sciences (Nanjing), Inc. is a global supplier of innovative products and services in the field of pharmaceutical research and manufacturing. The company focuses on improving the efficiency of drug discovery and development for its partners through innovative chemical and low-carbon technologies. Since its establishment in 2008, Pharmablock Sciences has collaborated with almost all of the top twenty pharmaceutical companies globally, as well as hundreds of small and medium-sized biotechnology companies. Pharmablock Sciences utilizes its unique molecular building block and compound library screening technology to support drug discovery. It also provides efficient and high-quality process development and production services for intermediate, active pharmaceutical ingredients, and drug formulations through its integrated CMC platform. Additionally, the company has accumulated capabilities in cutting-edge technologies such as continuous flow chemistry, micro-packed bed technology, catalysis, and intelligent manufacturing. It actively explores advanced manufacturing and service models that are green, safe, and intelligent in the field of biomedicine, promoting industry innovation and development.

Headquarters
10 Xuefu Rd. High-New Tech. Dev. Pk. Nanjing Jiangsu
Nanjing; Jiangsu; Postal Code: 210032

Contact Details: Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.

Website: http://www.pharmablock.com

Basic Information
Total Employees:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Outstanding Shares:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Registered Capital:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Financial Auditors:
Purchase the Pharmablock Sciences (Nanjing), Inc. report to view the information.
Incorporation Date:
December 26, 2006
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
20.69%
Purchase this report to view the information.
2.93%
Purchase this report to view the information.
2.93%
Purchase this report to view the information.
2.71%
Purchase this report to view the information.
2.63%
Subsidiaries
Jiangxi Shangshi Pharmaceutical Co., Ltd.
100%
Nanjing Anakang Biological Technology Co., Ltd.
100%
Nanjing Furun CapitaLand Biological Medicine Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Pharmablock Sciences (Nanjing), Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.56%
Total operating revenue
-3.88%
Operating profit (EBIT)
3.72%
EBITDA
-14.59%
Net Profit (Loss) for the Period
-14.32%
Total assets
-0.84%
Total equity
5.66%
Operating Profit Margin (ROS)
0.71%
Net Profit Margin
-1.95%
Return on Equity (ROE)
-0.4%
Debt to Equity Ratio
-21.95%
Quick Ratio
-0.49%
Cash Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?